Role of proteasomes in T cell activation and proliferation

被引:0
|
作者
Wang, X
Luo, HY
Chen, HF
Duguid, W
Wu, JP
机构
[1] Univ Montreal, Notre Dame Hosp, Louis Charles Simard Res Ctr, Lab Transplantat Immunol, Quebec City, PQ H2L 4M1, Canada
[2] Univ Montreal, Notre Dame Hosp, Serv Nephrol, Quebec City, PQ H2L 4M1, Canada
[3] McGill Univ, Montreal Gen Hosp, Montreal, PQ H3G 1A4, Canada
[4] McGill Univ, Dept Surg, Montreal, PQ H3G 1A4, Canada
来源
JOURNAL OF IMMUNOLOGY | 1998年 / 160卷 / 02期
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The role of proteasomes in T cell activation, proliferation, and apoptosis was investigated using a proteasome-specific inhibitor lactacystin (LAC), Inhibition of the proteasome activity by LAC repressed the mitogen-induced T cell proliferation, The proteasome activity was definitively required for the T cells to progress from the G(0) to S phase, It was necessary to optimize the progress from the G(1)/S boundary to the G(2)/M phase, but not for the progress from the G(2)/M phase to the next G(1) phase, Probably as a result of a blockage of cell cycle progress, the cycling, but not the resting, T cells underwent apoptosis when treated with LAG. Mechanistically, we have found that cyclin-dependent kinase-2 (CDK2) and the cyclin E-associated kinase (largely CDK2), but not CDK4, in the G(1) phase were strongly inhibited by LAG. This could be an important mechanism for the proteasome to regulate the cell cycle, The degradation of cyclin E in the late G(1) and early S phases was dependent on the proteasome, although it was unlikely that this accounted for the observed inhibition of T cell proliferation, There was a reduced decay of p27(Kip1) in the late G(1) phase when the proteasome activity was suppressed, and this might be a contributing mechanism for the observed inhibition of: CDK2 activity, Interestingly, p21(Cip1) was up-regulated during the G(1) phase, and the up-regulation was inhibited by LAG. Our study shows that the proteasome plays pivotal roles in regulating T cell activation and proliferation, and its effect is probably exerted through multiple mechanisms.
引用
收藏
页码:788 / 801
页数:14
相关论文
共 50 条
  • [1] The role of human β-defensin 2 in T cell activation and proliferation
    Chen, D.
    George, J.
    Rowley, D.
    Outram, S.
    IMMUNOLOGY, 2014, 143 : 62 - 63
  • [2] The inhibitory role of lactacystin and β-Lactacystin on T-cell activation and proliferation
    Song, PH
    Xie, HY
    Zheng, SS
    Wu, J
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2004, 36 (02) : 123 - 127
  • [3] ROLE OF EARLY-ACTIVATION ANTIGENS IN T-CELL PROLIFERATION
    UEDE, T
    YUASA, H
    KOHDA, H
    KIKUCHI, K
    OSAWA, H
    DIAMANTSTEIN, T
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1987, 494 : 287 - 290
  • [4] ROLE OF T-CELLS IN B-CELL ACTIVATION AND PROLIFERATION
    KUBOTA, E
    WALL, J
    DUTTON, RW
    SWAIN, SL
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1987, : 249 - 249
  • [5] Caspase activation is required for T cell proliferation
    Kennedy, NJ
    Kataoka, T
    Tschopp, J
    Budd, RC
    JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 190 (12): : 1891 - 1895
  • [6] METHYLDOPA INHIBITS T-CELL ACTIVATION AND PROLIFERATION
    KLOHE, EP
    MYERS, TA
    TRANSFUSION, 1994, 34 (10) : S78 - S78
  • [7] Effect of Boswellic acids on T cell proliferation and activation
    Meyiah, Abdo
    Shawkat, Murtada Y.
    Rehman, Najeeb Ur
    Al-Harrasi, Ahmed
    Elkord, Eyad
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2023, 122
  • [8] Helios Expression Is a Marker of T Cell Activation and Proliferation
    Akimova, Tatiana
    Beier, Ulf H.
    Wang, Liqing
    Levine, Matthew H.
    Hancock, Wayne W.
    PLOS ONE, 2011, 6 (08):
  • [9] Activation of GABA(A) receptors inhibits T cell proliferation
    Sparrow, Emma L.
    James, Sonya
    Hussain, Khiyam
    Beers, Stephen A.
    Cragg, Mark S.
    Bogdanov, Yury D.
    PLOS ONE, 2021, 16 (05):
  • [10] Activation of T-cell proliferation by Enseki sandbath
    Aragane, Yoshinori
    Higashino, Hideaki
    PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE, 2020, 36 (01) : 68 - 69